HOGAN LOVELLS

Comment: A leading pharma practice for many years, HL has stellar teams in all advisory fields relevant to the healthcare industry. It continues to advise its top-class client base on a broad range of issues from regulatory matters to product liability litigation and compliance investigations. The recent success of the product liability practice on behalf of TÜV Rheinland before the ECJ in the breast implant dispute was just one of many highlights over the past year. The work handled by the regulatory practice headed by the respected Schickert is becoming more and more international and was recently dominated by complex contract projects at the interfaces with regulatory matters and compliance. The German practice is increasingly advising US companies on transnational instructions. For one client, the German pharma experts coordinated an international compliance investigation. As in the previous year, work in the field of digital health continued to rise: HL often deals with some innovative topics here with instructions on data protection in the areas of gene diagnostics and the digitalization of study data.
Strengths: Regulatory and contract advice, IP (esp. ?patent litigation) and ?product liability, transactions ( ?M&A).
Recommended: Dr. Jörg Schickert (“many years of purely positive experiences, extremely knowledgeable, pragmatic support”, client), Dr. Andreas von Falck (patents), Ina Brock (product liability), Dr. Tanja Eisenblätter (“highly efficient, profound knowledge of competition disputes, unbeatable before the competition courts”, client), Arne Thiermann (“quick and straightforward”, competitor, counsel).
Practice: All-round advice to the healthcare sector. ?Compliance, product liability, social and reimbursement issues, transactions and biotech, pharma advertising, ?trademarks and unfair competition and demarcation issues between cosmetics and ?food. Patents and ?antitrust linked to pharma. Clients: mainly research industry and medical product manufacturers, also associations, many biotech companies, increasingly healthcare service providers. (Core team: 6 partners, 1 counsel, 10 associates)
Clients: ?? Frequent all-round advice to Baxter; all-round advice to Eli Lilly, incl. in proceedings on equivalent patent infringement; Foundation Medicine on law governing gene diagnostics and data protection; Lilly Deutschland in proceedings before the German Superior State Social Court on generics discount for insulin products; all-round advice to Nanobiotix on structuring a European distribution network and on clinical trials in ten countries; regulatory advice to Novartis.
  • Teilen